Trankvilan en es it fr

Trankvilan Brand names, Trankvilan Analogs

Trankvilan Brand Names Mixture

  • No information avaliable

Trankvilan Chemical_Formula


Trankvilan RX_link

No information avaliable

Trankvilan fda sheet

Trankvilan msds (material safety sheet)

Trankvilan Synthesis Reference

No information avaliable

Trankvilan Molecular Weight

309.469 g/mol

Trankvilan Melting Point

< 25 oC

Trankvilan H2O Solubility

Soluble as HCl salt

Trankvilan State


Trankvilan LogP


Trankvilan Dosage Forms

Tablets (oral, 1 mg)

Trankvilan Indication

Used for the symptomatic treatment of parkinsonism.

Trankvilan Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Trankvilan Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Trankvilan side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Trankvilan Patient Information

Trankvilan Organisms Affected

Humans and other mammals